Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial

Charlene S. Dezzutti, Barbra A. Richardson, Jeanne M. Marrazzo, Jessica Tugetman, Gita Ramjee, Taha Taha, Zvavahera M. Chirenje, Salim S. Abdool Karim, Sharon L. Hillier, Betsy Herold

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The mucosal environment may impact the risk for human immunodeficiency virus type 1 (HIV-1) acquisition. Immune mediators were measured in vaginal fluid collected from HPTN 035 participants who acquired HIV-1 and from those who remained HIV-1 negative (controls). Mediator concentrations were similar in samples obtained before as compared to after HIV-1 acquisition in the 8 seroconverters. Compared with controls, seroconverters were more likely to have detectable levels of HD-2 (odds ratio [OR], 2.39; P =. 005) and greater Escherichia coli bactericidal activity (OR, 1.22; P =. 01) prior to seroconversion. E. coli bactericidal activity remained significant in a multivariable analysis (P =. 02) and may be a biomarker for HIV-1 acquisition.

Original languageEnglish (US)
Pages (from-to)1931-1935
Number of pages5
JournalJournal of Infectious Diseases
Volume206
Issue number12
DOIs
StatePublished - Dec 15 2012

Fingerprint

HIV-1
Escherichia coli
Odds Ratio
Biomarkers
Seroconversion

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. / Dezzutti, Charlene S.; Richardson, Barbra A.; Marrazzo, Jeanne M.; Tugetman, Jessica; Ramjee, Gita; Taha, Taha; Chirenje, Zvavahera M.; Abdool Karim, Salim S.; Hillier, Sharon L.; Herold, Betsy.

In: Journal of Infectious Diseases, Vol. 206, No. 12, 15.12.2012, p. 1931-1935.

Research output: Contribution to journalArticle

Dezzutti, CS, Richardson, BA, Marrazzo, JM, Tugetman, J, Ramjee, G, Taha, T, Chirenje, ZM, Abdool Karim, SS, Hillier, SL & Herold, B 2012, 'Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial', Journal of Infectious Diseases, vol. 206, no. 12, pp. 1931-1935. https://doi.org/10.1093/infdis/jis555
Dezzutti, Charlene S. ; Richardson, Barbra A. ; Marrazzo, Jeanne M. ; Tugetman, Jessica ; Ramjee, Gita ; Taha, Taha ; Chirenje, Zvavahera M. ; Abdool Karim, Salim S. ; Hillier, Sharon L. ; Herold, Betsy. / Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. In: Journal of Infectious Diseases. 2012 ; Vol. 206, No. 12. pp. 1931-1935.
@article{b117ade2869b47e0ac63c8341dfeaffd,
title = "Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial",
abstract = "The mucosal environment may impact the risk for human immunodeficiency virus type 1 (HIV-1) acquisition. Immune mediators were measured in vaginal fluid collected from HPTN 035 participants who acquired HIV-1 and from those who remained HIV-1 negative (controls). Mediator concentrations were similar in samples obtained before as compared to after HIV-1 acquisition in the 8 seroconverters. Compared with controls, seroconverters were more likely to have detectable levels of HD-2 (odds ratio [OR], 2.39; P =. 005) and greater Escherichia coli bactericidal activity (OR, 1.22; P =. 01) prior to seroconversion. E. coli bactericidal activity remained significant in a multivariable analysis (P =. 02) and may be a biomarker for HIV-1 acquisition.",
author = "Dezzutti, {Charlene S.} and Richardson, {Barbra A.} and Marrazzo, {Jeanne M.} and Jessica Tugetman and Gita Ramjee and Taha Taha and Chirenje, {Zvavahera M.} and {Abdool Karim}, {Salim S.} and Hillier, {Sharon L.} and Betsy Herold",
year = "2012",
month = "12",
day = "15",
doi = "10.1093/infdis/jis555",
language = "English (US)",
volume = "206",
pages = "1931--1935",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial

AU - Dezzutti, Charlene S.

AU - Richardson, Barbra A.

AU - Marrazzo, Jeanne M.

AU - Tugetman, Jessica

AU - Ramjee, Gita

AU - Taha, Taha

AU - Chirenje, Zvavahera M.

AU - Abdool Karim, Salim S.

AU - Hillier, Sharon L.

AU - Herold, Betsy

PY - 2012/12/15

Y1 - 2012/12/15

N2 - The mucosal environment may impact the risk for human immunodeficiency virus type 1 (HIV-1) acquisition. Immune mediators were measured in vaginal fluid collected from HPTN 035 participants who acquired HIV-1 and from those who remained HIV-1 negative (controls). Mediator concentrations were similar in samples obtained before as compared to after HIV-1 acquisition in the 8 seroconverters. Compared with controls, seroconverters were more likely to have detectable levels of HD-2 (odds ratio [OR], 2.39; P =. 005) and greater Escherichia coli bactericidal activity (OR, 1.22; P =. 01) prior to seroconversion. E. coli bactericidal activity remained significant in a multivariable analysis (P =. 02) and may be a biomarker for HIV-1 acquisition.

AB - The mucosal environment may impact the risk for human immunodeficiency virus type 1 (HIV-1) acquisition. Immune mediators were measured in vaginal fluid collected from HPTN 035 participants who acquired HIV-1 and from those who remained HIV-1 negative (controls). Mediator concentrations were similar in samples obtained before as compared to after HIV-1 acquisition in the 8 seroconverters. Compared with controls, seroconverters were more likely to have detectable levels of HD-2 (odds ratio [OR], 2.39; P =. 005) and greater Escherichia coli bactericidal activity (OR, 1.22; P =. 01) prior to seroconversion. E. coli bactericidal activity remained significant in a multivariable analysis (P =. 02) and may be a biomarker for HIV-1 acquisition.

UR - http://www.scopus.com/inward/record.url?scp=84870208216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870208216&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis555

DO - 10.1093/infdis/jis555

M3 - Article

VL - 206

SP - 1931

EP - 1935

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 12

ER -